NAYA Biosciences, Inc. financial data

Symbol
NAYA on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
5582 Broadcast Court, Sarasota, FL
State of incorporation
NV
Fiscal year end
December 31
Former names
INVO Bioscience, Inc. (to 10/15/2024), EMY'S SALSA AJI DISTRIBUTION COMPANY, INC. (to 1/5/2009)
Latest financial report
10-Q - Q3 2024 - Nov 19, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 22 % -39.1%
Quick Ratio 3.06 % -51.9%
Debt-to-equity 3.05K %
Return On Equity 1.59K %
Return On Assets -42.3 % +61.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 4.94M shares
Common Stock, Shares, Outstanding 3.91M shares +57.8%
Entity Public Float 3.07M USD -60.4%
Common Stock, Value, Issued 391 USD +58.3%
Weighted Average Number of Shares Outstanding, Basic 3.89M shares +119%
Weighted Average Number of Shares Outstanding, Diluted 3.89M shares +119%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 6.23M USD +225%
Cost of Revenue 988K USD +70.1%
Research and Development Expense 97.3K USD -81%
Costs and Expenses 2.73M USD +46.9%
Operating Income (Loss) -5.66M USD +29.1%
Nonoperating Income (Expense) -1.75M USD -113%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -7.41M USD -28.5%
Income Tax Expense (Benefit) 29.3K USD +1451%
Net Income (Loss) Attributable to Parent -7.47M USD +15.2%
Earnings Per Share, Basic -0.42 USD/shares +40%
Earnings Per Share, Diluted -0.42 USD/shares +40%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1.96M USD -70.5%
Accounts Receivable, after Allowance for Credit Loss, Current 257K USD +120%
Inventory, Net 242K USD -4.99%
Assets, Current 1.96M USD +9.25%
Property, Plant and Equipment, Net 415K USD -46.2%
Operating Lease, Right-of-Use Asset 2.34M USD -31.5%
Intangible Assets, Net (Excluding Goodwill) 3.48M USD +98.9%
Goodwill 5.88M USD -28.5%
Assets 17M USD -0.12%
Employee-related Liabilities, Current 640K USD +8.37%
Liabilities, Current 8.66M USD +85.4%
Deferred Income Tax Liabilities, Net 1.95K USD +71.1%
Operating Lease, Liability, Noncurrent 2.25M USD -33.8%
Liabilities 17M USD +2.25%
Retained Earnings (Accumulated Deficit) -63.5M USD -13.8%
Stockholders' Equity Attributable to Parent -23.3K USD -106%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 373K USD -71%
Liabilities and Equity 17M USD -12.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -261K USD +77.3%
Net Cash Provided by (Used in) Financing Activities 527K USD -83.8%
Net Cash Provided by (Used in) Investing Activities -24.1K USD -185%
Common Stock, Shares Authorized 50M shares 0%
Common Stock, Shares, Issued 3.91M shares +57.8%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 243K USD -88.4%
Interest Paid, Excluding Capitalized Interest, Operating Activities 50.8K USD
Deferred Tax Assets, Valuation Allowance 11.1M USD +19.4%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0 pure
Deferred Tax Assets, Gross 11.7M USD +21.2%
Operating Lease, Liability 2.48M USD -58.7%
Depreciation 95.7K USD +10.7%
Payments to Acquire Property, Plant, and Equipment 49.7K USD
Lessee, Operating Lease, Liability, to be Paid 3.97M USD -50.2%
Operating Lease, Liability, Current 231K USD +36.3%
Lessee, Operating Lease, Liability, to be Paid, Year Two 519K USD -16.7%
Lessee, Operating Lease, Liability, to be Paid, Year One 506K USD -17.9%
Operating Lease, Weighted Average Discount Rate, Percent 0.12 pure
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.49M USD -24.1%
Lessee, Operating Lease, Liability, to be Paid, Year Three 490K USD -23.3%
Deferred Tax Assets, Operating Loss Carryforwards 10.3M USD +22.2%
Preferred Stock, Shares Issued 1.2M shares
Preferred Stock, Shares Authorized 1.2M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 632K USD +150%
Additional Paid in Capital 47.8M USD +17%
Preferred Stock, Shares Outstanding 1.2M shares
Amortization of Intangible Assets 613K USD +135547%
Depreciation, Depletion and Amortization 227K USD +1089%
Interest Expense 891K USD +224%